Indianapolis-based Eli Lilly and Co. is ramping up its campaign against imitations of its blockbuster appetite-suppressing drugs, seeking to put an end to a regulatory designation that has allowed ...

Since the start of 2020, Eli Lilly’s (NYSE: LLY) stock price chart has been straight up and to the right, up 626.12% and ...

International drugmaker, Eli Lilly, announced plans in May to invest $5.3 billion (€4.9 billion) in a new manufacturing site ...

Deutsche Bank has recently raised Eli Lilly And Co (LLY) stock to Buy rating, as announced on August 12, 2024, according to Finviz. Earlier, on February 21, 2024, DZ Bank had reduced the stock from a ...

The surge in interest investors have displayed for companies delivering weight loss drugs has been impressive. Indeed, the ...

Meta, Costco and Eli Lilly along with two others are trading near buy points coming out of a week marked by Nvidia earnings.

Eli Lilly is acquisitive, too, and just purchased a company called Morphic Holding. The acquisition expands the healthcare ...

Cobalt has appointed Sonali Shah as its new Chief Executive Officer. Shah, originally from Potomac, MD, brings over two ...

Cybersecurity expert Sonali Shah takes the helm at Cobalt to drive innovation and growth in the Pentest as a Service sector, ...

Analyst Akash Tewari of Jefferies maintained a Buy rating on Eli Lilly & Co (LLY – Research Report), boosting the price target to ...

Eli Lilly has announced the availability of Zepbound (tirzepatide) in 2.5mg and 5mg single-dose vials for self-pay for adults ...

The launch of a single-use vial form of the popular weight loss medicine could help Lilly improve supply and compete with telehealth companies offering compounded versions.